Treatment Page 2 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Bexagliflozin for patients with type 2 diabetes

Posted by on Aug 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to evaluate the safety and effectiveness of bexagliflozin in patients with type 2 diabetes (T2D). The study found that this treatment was safe and significantly improved the outcomes of these patients. Some background Bexagliflozin is a new medication for treating T2D. It is part of a larger class of...

Read More

Can metformin help reduce the risk of developing neurodegenerative disease in elderly patients with T2D?

Posted by on Aug 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if metformin (Glucophage) helped reduce the risk of neurodegenerative disease in elderly patients with Type 2 diabetes (T2D). The authors found that patients taking metformin for more than two years had a lower risk of brain degeneration diseases compared to patients not taking metformin. Some...

Read More

Evaluating GVDex chemotherapy for patients with recurrent or persistent Hodgkin’s lymphoma

Posted by on Aug 19, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if GVDex is as effective and safe as GVDoxil for treating Hodgkin's lymphoma (HL) that has come back or stopped responding to treatment. The authors found that GVDex was as effective as GVDoxil, with fewer side effects. Some background For most patients with HL, primary therapy is highly effective....

Read More

Can linagliptin improve glucose control in older people with type 2 diabetes?

Posted by on Aug 18, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if linagliptin (Tradjenta) was safer and more effective in older patients with Type 2 diabetes compared to a placebo. This study concluded that linagliptin helped improve glucose control for these patients without causing additional side effects. Some background About 90% of diabetes cases are of Type 2 diabetes...

Read More

Chemoradiotherapy versus radiation only – which is more effective in inoperable lung cancer?

Posted by on Aug 17, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of radiation therapy (RT) and chemoradiotherapy (CRT) in inoperable non-small cell lung cancer (NSCLC). They found that CRT was more effective than RT alone in these patients.  Some background Non-small cell lung cancer (NSCLC) is the most common form of lung cancer (LC)....

Read More

A triple fixed combination of atorvastatin, perindopril and amlodipine for the treatment of hypertension and high cholesterol

Posted by on Aug 17, 2019 in Hypertension | 0 comments

In a nutshell This study investigated a fixed-dose combination (FDC) of atorvastatin (Lipitor), perindopril (Coversyl) and amlodipine (Norvasc) to treat patients with hypertension and high cholesterol levels. They found that this combination was effective in reducing blood pressure (BP) and cholesterol...

Read More

Acupuncture and angina – can alternative medicine improve disease management?

Posted by on Aug 17, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of acupuncture on angina management. They found that acupuncture reduced the rate of angina attacks.  Some background Coronary artery disease (CAD) is caused by reduced blood flow to the heart. Angina is the term used to describe chest pain due to reduced blood flow. Many patients with CAD...

Read More

Evaluating nivolumab plus brentuximab vedotin for patients with relapsed or unresponsive primary mediastinal large B-cell lymphoma

Posted by on Aug 17, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated nivolumab (Opdivo) plus brentuximab vedotin (Adcetris) in patients with relapsed or unresponsive primary mediastinal B-cell lymphoma (PMBCL). This study concluded that this combination is promising and was well-tolerated. Some background PMBCL is a rare but aggressive type of non-Hodgkin’s lymphoma (NHL)....

Read More